Sign up to save your podcasts
Or
Share Do You Seek and Do You Use Molecular Marker Information in Patients with Early Stage NSCLC?
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Do You Seek and Do You Use Molecular Marker Information in Patients with Early Stage NSCLC?
Dr. Karen Kelly of University of California, Davis, presents her current view on using molecular markers in early stage non-small cell lung cancer and explains the RADIANT study that she leads.
View all episodes
By cancerGRACE - H. Jack West, MD
5
11 ratings
Dr. Karen Kelly of University of California, Davis, presents her current view on using molecular markers in early stage non-small cell lung cancer and explains the RADIANT study that she leads.
More shows like GRACEcast Lung Cancer Video
View all
GRACEcast Head and Neck Cancer Audio
2 Listeners
GRACEcast Radiation Oncology Audio
0 Listeners
GRACEcast Radiation Oncology Video
0 Listeners
GRACEcast Pancreatic Cancer Audio
0 Listeners
GRACEcast Pancreatic Cancer Video
1 Listeners
GRACEcast Cancer 101 Audio
0 Listeners
GRACEcast Bladder Cancer Video
0 Listeners
GRACEcast Head and Neck Cancer Video NEW
0 Listeners
GRACEcast Cancer 101 Video
0 Listeners